Division of Pediatric Critical Care Medicine, Department of Pediatrics, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, WA.
Children's Hospital Association, Lenexa, KS.
Pediatr Crit Care Med. 2018 Jun;19(6):519-527. doi: 10.1097/PCC.0000000000001535.
To characterize and compare antibiotic prescribing across PICUs to evaluate the degree of variability.
Retrospective analysis from 2010 through 2014 of the Pediatric Health Information System.
Forty-one freestanding children's hospital.
Children aged 30 days to 18 years admitted to a PICU in children's hospitals contributing data to Pediatric Health Information System.
To normalize for potential differences in disease severity and case mix across centers, a subanalysis was performed of children admitted with one of the 20 All Patient Refined-Diagnosis Related Groups and the seven All Patient Refined-Diagnosis Related Groups shared by all PICUs with the highest antibiotic use.
The study included 3,101,201 hospital discharges from 41 institutions with 386,914 PICU patients. All antibiotic use declined during the study period. The median-adjusted antibiotic use among PICU patients was 1,043 days of therapy/1,000 patient-days (interquartile range, 977-1,147 days of therapy/1,000 patient-days) compared with 893 among non-ICU children (interquartile range, 805-968 days of therapy/1,000 patient-days). For PICU patients, the median adjusted use of broad-spectrum antibiotics was 176 days of therapy/1,000 patient-days (interquartile range, 152-217 days of therapy/1,000 patient-days) and was 302 days of therapy/1,000 patient-days (interquartile range, 220-351 days of therapy/1,000 patient-days) for antimethicillin-resistant Staphylococcus aureus agents, compared with 153 days of therapy/1,000 patient-days (interquartile range, 130-182 days of therapy/1,000 patient-days) and 244 days of therapy/1,000 patient-days (interquartile range, 203-270 days of therapy/1,000 patient-days) for non-ICU children. After adjusting for potential confounders, significant institutional variability existed in antibiotic use in PICU patients, in the 20 All Patient Refined-Diagnosis Related Groups with the highest antibiotic usage and in the seven All Patient Refined-Diagnosis Related Groups shared by all 41 PICUs.
The wide variation in antibiotic use observed across children's hospital PICUs suggests inappropriate antibiotic use.
通过对儿科重症监护病房(PICU)的抗生素使用情况进行特征描述和比较,评估其变异性程度。
对 2010 年至 2014 年期间儿科健康信息系统的回顾性分析。
41 家独立的儿童医院。
在参与儿科健康信息系统数据的儿童医院中,年龄在 30 天至 18 岁之间、入住 PICU 的儿童。
为了对各中心间潜在的疾病严重程度和病例组合差异进行标准化,对使用抗生素最多的 20 个全患者精细化诊断相关组和 7 个全患者精细化诊断相关组中每个组内的一个全患者精细化诊断相关组的儿童进行亚组分析。
研究纳入了来自 41 家机构的 3101201 例出院患者,其中有 386914 例 PICU 患者。研究期间所有抗生素的使用均呈下降趋势。与非 ICU 儿童(977-1048 天治疗/1000 患者天)相比,PICU 患者的中位调整后抗生素使用率为 1043 天治疗/1000 患者天(四分位距,977-1147 天治疗/1000 患者天)。对于 PICU 患者,广谱抗生素的中位调整使用率为 176 天治疗/1000 患者天(四分位距,152-217 天治疗/1000 患者天),耐甲氧西林金黄色葡萄球菌药物的使用率为 302 天治疗/1000 患者天(四分位距,220-351 天治疗/1000 患者天),而非 ICU 儿童的使用率分别为 153 天治疗/1000 患者天(四分位距,130-182 天治疗/1000 患者天)和 244 天治疗/1000 患者天(四分位距,203-270 天治疗/1000 患者天)。在调整了潜在混杂因素后,在使用抗生素最多的 20 个全患者精细化诊断相关组和所有 41 家 PICU 共同使用的 7 个全患者精细化诊断相关组中,PICU 患者的抗生素使用仍存在显著的机构间差异。
儿童 PICU 间抗生素使用的广泛差异表明存在不适当的抗生素使用。